細胞健康診断の世界市場規模、シェア、産業動向分析レポート：サンプルタイプ別、採取部位別、検査タイプ別、地域別展望と予測、2022年～2028年

細胞ヘルススクリーニングの世界市場規模は、2028年までに43億米ドルに達し、予測期間中にCAGR 9.0%で上昇すると予測されています。

精密医療の重要な要素は、細胞ヘルススクリーニングによって実現される治療オプションの容易なモニタリングとコントロールです。さらに、細胞活性と筋肉量に関する情報を提供するため、定期健康診断での採用が進んでいます。

健康上の問題や病気の可能性を調べるために、自覚症状がない場合はスクリーニング検査が行われます。その目的は、病気の可能性を低くするため、または最善の治療を受けるために早期に発見し、ライフスタイルを改善し、または監視することです。

COVID-19影響度分析

COVID-19の大流行の結果、携帯電話による健康診断の製品やサービスを提供する企業は、収益と基本検査量の減少を経験しました。パンデミックに関連する政府の指令に加え、輸送の制約や商品と原材料の輸出入の禁止により、サプライチェーンが阻害されました。その結果、多くの企業は、サプライチェーンの中断によってもたらされた需要の減少に対応するため、COVID-19抗体検査や分子検査を取り入れた製品提供を拡大し、基本検査能力の減少とバランスを取ることができました。

市場の成長要因

世界の高齢者人口の増加

加齢や生活習慣の乱れが人体における食生活のアンバランスの主な原因となるため、細胞の健康診断が欠かせないです。栄養レベルを高めるためのサプリメントも市販されています。酸化ストレス、疲労、ストレスだけでなく、その他の症状の根本的な原因は、細胞の健康状態の低下です。しかし、必要な栄養素が不足していると、次第に細胞の正常な活動が制限され、病気になります。すべての細胞が最適に動作するために必要な酵素であるNAD+のレベルは、40歳から60歳の間に半分に減少すると言われています。さらに、テロメアが短くなると、肝臓の病気、肺線維症、骨髄不全など、さまざまな副作用を引き起こす可能性があります。

個別化医薬品の使用拡大

細胞ヘルススクリーニングの普及は、個別化医療における利用が拡大していることに起因しています。国際個別化医療コンソーシアム（ICPerMed）は、生物医学、社会科学、経済科学の進歩とともに、技術革新がPMを推進するものであると考えています。したがって、その成功のためには、技術革新と研究への多大な投資が必要です。個別化医療は、一般的に2つの要素から構成されています。生物学的製剤、薬物療法、その他の治療的介入が第一の構成要素であり、診断テストが第二の構成要素です。

市場抑制要因

細胞スクリーニングキットの高コストと専門従事者の不足

携帯型健康診断キットはコストが高いため、大多数の人が一定以上使用することができません。細胞ヘルススクリーニングの成長に影響を与えるもうひとつの側面は、サンプルの壊れやすさとキットの不安定さです。この2つは、プログラムの応答性とプロセスの効率性を低下させます。そのメンテナンスの高さから、特にサンプル採取が制限されているケースでは、すべてのケースで使用するのは不適当とされています。さらに、サンプル輸送の課題が増加し、払い戻し政策が不利になることで、携帯型健康診断キットの好みが低下しています。

サンプルタイプの展望

サンプルの種類によって、細胞ヘルススクリーニング市場は血液、唾液、血清、尿に分けられます。尿サンプルセグメントは、2021年のセルラーヘルススクリーニング市場で大きな収益シェアを示しました。尿の採取は技術者を必要とせず、非侵襲的であるため、患者に優しく、著しく迅速です。さらに、尿スクリーニングが酸化ストレスを正確に評価する可能性があることが研究で示されています。例えば、日本の研究者は、喫煙と酸化ストレスが尿中のプテリジン化合物のレベルに関連していることを研究論文で実証しました。その結果、体内の酸化ストレスのスクリーニングが進み、尿サンプル型スクリーニングの市場は上昇すると予測されます。

採取部位の展望

細胞ヘルススクリーニング市場は、採取部位によって、家庭、オフィス、病院、診断ラボに区分されます。家庭用セグメントは、2021年の細胞ヘルススクリーニング市場において有望な収益シェアを調達しました。これは、健康意識の高まりと、重要なマーケットプレースでの自己サンプリングの普及によって説明されます。セルフサンプリングは、使い方が簡単で、専門的な機器や有資格者を必要としないため、人気を博しています。また、COVID-19の大流行により、移動が制限されたため、自宅採取に傾倒する傾向が広まり、この傾向は今後も続くと思われます。

検査タイプ別の展望

細胞ヘルススクリーニング市場は、検査タイプによってシングルテストパネルとマルチテストパネルに分類されます。シングルテストパネルは、2021年に最も高い収益シェアで細胞ヘルススクリーニング市場を独占しています。シングルパネル検査用の製品は、特定の特定クラスの疾患に対して、手頃な価格で、正確かつ迅速なスクリーニングを提供します。シンプルなシングルパネル検査では、サンプルを使用して、疾患の前駆物質となり得るバイオマーカーを検出します。このような診断検査は、職場や自宅など、ビジネスとプライベートの両方で実施することができます。数分以内に、目に見え、理解しやすい定性的なデータが得られます。

酸化ストレス検査の展望

単一検査パネル部門は、さらにテロメア検査、酸化ストレス検査、炎症検査、重金属検査に分けられます。酸化ストレス検査は、2021年に細胞ヘルススクリーニング市場で最大の収益シェアを獲得しました。がん、呼吸器疾患、糖尿病、心血管疾患、およびその他の疾患は、これらの検査によって助けられます。酸化ストレスは、フリーラジカル（ROS、活性酸素種）の生成と、体内にすでに存在する抗酸化力（AC）との間の不均衡の結果です。抗酸化力が高まると活性酸素の発生が抑えられ、逆に抗酸化力が高まると活性酸素の値が低下することが多いです。

地域別の展望

地域別に見ると、細胞ヘルススクリーニング市場は北米、欧州、アジア太平洋、LAMEAで分析されています。2021年の細胞ヘルススクリーニング市場では、北米地域が最大の収益シェアを記録しました。この地域の主な貢献要素としては、健康でいられる期間を示す健康寿命（HALE）、医療費の上昇、予防医療に対する政府のサポートなどが挙げられます。さらに、重要な企業の存在、新技術の採用の容易さ、国民の慢性疾患や感染症の流行などが、この地域の成長に寄与しています。

細胞ヘルススクリーニング市場のレポート対象範囲。

レポート属性の詳細

2021年の市場規模値 24億米ドル

2028年の市場規模予測USD 4.3 Billion

基準年 2021年

過去期間2018年から2020年

予測期間2022年～2028年

2022年から2028年までの収益成長率CAGR9%。

ページ数250

表460

レポート対象市場動向・収益推計・予測、セグメント別分析、地域・国別内訳、企業の戦略的展開、企業プロファイル

対象セグメントサンプルタイプ,採取部位,検査タイプ,地域

国別米国、カナダ、メキシコ、ドイツ、英国、フランス、ロシア、スペイン、イタリア、中国、日本、インド、韓国、シンガポール、オーストラリア、ブラジル、アルゼンチン、UAE、サウジアラビア、南アフリカ、ナイジェリア

促進要因：世界の老年人口の増加

個別化医薬品の使用拡大

抑制要因：細胞スクリーニングキットの高コストと専門従事者の不足

目次

第1章 市場の範囲と調査手法

• 市場の定義
• 目的
• 市場規模
• セグメンテーション
  • 細胞ヘルススクリーニングの世界市場、サンプルタイプ別
  • 細胞ヘルススクリーニングの世界市場、採取部位別
  • 細胞ヘルススクリーニングの世界市場、テストタイプ別
  • 細胞ヘルススクリーニングの世界市場、地域別
• 調査手法

第2章 市場概要

• イントロダクション
  • 概要説明
    • 市場の構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第3章 細胞ヘルススクリーニングの世界市場：サンプルタイプ別

• 血液の世界市場：地域別
• 唾液の世界市場：地域別
• 血清の世界市場：地域別
• 尿の世界市場：地域別

第4章 細胞ヘルススクリーニングの世界市場：採取部位別

• 地域別病院の世界市場
• 診断ラボの世界市場：地域別
• 世界の家庭用市場：地域別
• 世界のオフィス市場：地域別

第5章 細胞ヘルススクリーニングの世界市場：検査タイプ別

• シングルテストパネルの世界市場：地域別
• 細胞ヘルススクリーニングの世界市場：シングルテストパネルタイプ別
  • 酸化ストレス検査の世界市場：地域別
  • 炎症検査の世界市場：地域別
  • テロメア検査の世界市場：地域別
  • 重金属検査の世界市場：地域別
• マルチテストパネルの世界市場：地域別

第6章 細胞ヘルススクリーニングの世界市場：地域別

• 北米
  • 北米の細胞ヘルススクリーニングの市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の細胞ヘルススクリーニングの市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州
• アジア太平洋地域
  • アジア太平洋地域の細胞ヘルススクリーニングの市場：国別
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • マレーシア
    • その他アジア太平洋地域
• LAMEA
  • LAMEAの細胞ヘルススクリーニングの市場：国別
    • ブラジル
    • アルゼンチン
    • UAE
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他のLAMEA

第7章 企業プロファイル

• Quest Diagnostics Incorporated
• OPKO Health, Inc.
• Laboratory Corporation of America Holdings
• Genova Diagnostics
• Telomere Diagnostics, Inc.
• Life Length, S.L
• Repeat Diagnostics, Inc.
• SpectraCell Laboratories, Inc.（Beingmate Group Co. Ltd.）
• Cell Science Systems Corp
• Segterra, Inc.（INSIDETRACKER）

LIST OF TABLES

• TABLE 1 Global Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 2 Global Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 3 Global Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 4 Global Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 5 Global Blood Market by Region, 2018 - 2021, USD Million
• TABLE 6 Global Blood Market by Region, 2022 - 2028, USD Million
• TABLE 7 Global Saliva Market by Region, 2018 - 2021, USD Million
• TABLE 8 Global Saliva Market by Region, 2022 - 2028, USD Million
• TABLE 9 Global Serum Market by Region, 2018 - 2021, USD Million
• TABLE 10 Global Serum Market by Region, 2022 - 2028, USD Million
• TABLE 11 Global Urine Market by Region, 2018 - 2021, USD Million
• TABLE 12 Global Urine Market by Region, 2022 - 2028, USD Million
• TABLE 13 Global Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 14 Global Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 15 Global Hospital Market by Region, 2018 - 2021, USD Million
• TABLE 16 Global Hospital Market by Region, 2022 - 2028, USD Million
• TABLE 17 Global Diagnostic Labs Market by Region, 2018 - 2021, USD Million
• TABLE 18 Global Diagnostic Labs Market by Region, 2022 - 2028, USD Million
• TABLE 19 Global Home Market by Region, 2018 - 2021, USD Million
• TABLE 20 Global Home Market by Region, 2022 - 2028, USD Million
• TABLE 21 Global Office Market by Region, 2018 - 2021, USD Million
• TABLE 22 Global Office Market by Region, 2022 - 2028, USD Million
• TABLE 23 Global Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 24 Global Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 25 Global Single Test Panels Market by Region, 2018 - 2021, USD Million
• TABLE 26 Global Single Test Panels Market by Region, 2022 - 2028, USD Million
• TABLE 27 Global Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 28 Global Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 29 Global Oxidative Stress Tests Market by Region, 2018 - 2021, USD Million
• TABLE 30 Global Oxidative Stress Tests Market by Region, 2022 - 2028, USD Million
• TABLE 31 Global Inflammation Tests Market by Region, 2018 - 2021, USD Million
• TABLE 32 Global Inflammation Tests Market by Region, 2022 - 2028, USD Million
• TABLE 33 Global Telomere Tests Market by Region, 2018 - 2021, USD Million
• TABLE 34 Global Telomere Tests Market by Region, 2022 - 2028, USD Million
• TABLE 35 Global Heavy Metals Tests Market by Region, 2018 - 2021, USD Million
• TABLE 36 Global Heavy Metals Tests Market by Region, 2022 - 2028, USD Million
• TABLE 37 Global Multi-test Panels Market by Region, 2018 - 2021, USD Million
• TABLE 38 Global Multi-test Panels Market by Region, 2022 - 2028, USD Million
• TABLE 39 Global Cellular Health Screening Market by Region, 2018 - 2021, USD Million
• TABLE 40 Global Cellular Health Screening Market by Region, 2022 - 2028, USD Million
• TABLE 41 North America Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 42 North America Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 43 North America Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 44 North America Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 45 North America Blood Market by Country, 2018 - 2021, USD Million
• TABLE 46 North America Blood Market by Country, 2022 - 2028, USD Million
• TABLE 47 North America Saliva Market by Country, 2018 - 2021, USD Million
• TABLE 48 North America Saliva Market by Country, 2022 - 2028, USD Million
• TABLE 49 North America Serum Market by Country, 2018 - 2021, USD Million
• TABLE 50 North America Serum Market by Country, 2022 - 2028, USD Million
• TABLE 51 North America Urine Market by Country, 2018 - 2021, USD Million
• TABLE 52 North America Urine Market by Country, 2022 - 2028, USD Million
• TABLE 53 North America Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 54 North America Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 55 North America Hospital Market by Country, 2018 - 2021, USD Million
• TABLE 56 North America Hospital Market by Country, 2022 - 2028, USD Million
• TABLE 57 North America Diagnostic Labs Market by Country, 2018 - 2021, USD Million
• TABLE 58 North America Diagnostic Labs Market by Country, 2022 - 2028, USD Million
• TABLE 59 North America Home Market by Country, 2018 - 2021, USD Million
• TABLE 60 North America Home Market by Country, 2022 - 2028, USD Million
• TABLE 61 North America Office Market by Country, 2018 - 2021, USD Million
• TABLE 62 North America Office Market by Country, 2022 - 2028, USD Million
• TABLE 63 North America Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 64 North America Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 65 North America Single Test Panels Market by Country, 2018 - 2021, USD Million
• TABLE 66 North America Single Test Panels Market by Country, 2022 - 2028, USD Million
• TABLE 67 North America Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 68 North America Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 69 North America Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
• TABLE 70 North America Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
• TABLE 71 North America Inflammation Tests Market by Country, 2018 - 2021, USD Million
• TABLE 72 North America Inflammation Tests Market by Country, 2022 - 2028, USD Million
• TABLE 73 North America Telomere Tests Market by Country, 2018 - 2021, USD Million
• TABLE 74 North America Telomere Tests Market by Country, 2022 - 2028, USD Million
• TABLE 75 North America Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
• TABLE 76 North America Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
• TABLE 77 North America Multi-test Panels Market by Country, 2018 - 2021, USD Million
• TABLE 78 North America Multi-test Panels Market by Country, 2022 - 2028, USD Million
• TABLE 79 North America Cellular Health Screening Market by Country, 2018 - 2021, USD Million
• TABLE 80 North America Cellular Health Screening Market by Country, 2022 - 2028, USD Million
• TABLE 81 US Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 82 US Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 83 US Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 84 US Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 85 US Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 86 US Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 87 US Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 88 US Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 89 US Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 90 US Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 91 Canada Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 92 Canada Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 93 Canada Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 94 Canada Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 95 Canada Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 96 Canada Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 97 Canada Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 98 Canada Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 99 Canada Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 100 Canada Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 101 Mexico Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 102 Mexico Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 103 Mexico Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 104 Mexico Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 105 Mexico Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 106 Mexico Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 107 Mexico Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 108 Mexico Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 109 Mexico Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 110 Mexico Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 111 Rest of North America Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 112 Rest of North America Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 113 Rest of North America Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 114 Rest of North America Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 115 Rest of North America Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 116 Rest of North America Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 117 Rest of North America Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 118 Rest of North America Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 119 Rest of North America Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 120 Rest of North America Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 121 Europe Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 122 Europe Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 123 Europe Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 124 Europe Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 125 Europe Blood Market by Country, 2018 - 2021, USD Million
• TABLE 126 Europe Blood Market by Country, 2022 - 2028, USD Million
• TABLE 127 Europe Saliva Market by Country, 2018 - 2021, USD Million
• TABLE 128 Europe Saliva Market by Country, 2022 - 2028, USD Million
• TABLE 129 Europe Serum Market by Country, 2018 - 2021, USD Million
• TABLE 130 Europe Serum Market by Country, 2022 - 2028, USD Million
• TABLE 131 Europe Urine Market by Country, 2018 - 2021, USD Million
• TABLE 132 Europe Urine Market by Country, 2022 - 2028, USD Million
• TABLE 133 Europe Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 134 Europe Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 135 Europe Hospital Market by Country, 2018 - 2021, USD Million
• TABLE 136 Europe Hospital Market by Country, 2022 - 2028, USD Million
• TABLE 137 Europe Diagnostic Labs Market by Country, 2018 - 2021, USD Million
• TABLE 138 Europe Diagnostic Labs Market by Country, 2022 - 2028, USD Million
• TABLE 139 Europe Home Market by Country, 2018 - 2021, USD Million
• TABLE 140 Europe Home Market by Country, 2022 - 2028, USD Million
• TABLE 141 Europe Office Market by Country, 2018 - 2021, USD Million
• TABLE 142 Europe Office Market by Country, 2022 - 2028, USD Million
• TABLE 143 Europe Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 144 Europe Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 145 Europe Single Test Panels Market by Country, 2018 - 2021, USD Million
• TABLE 146 Europe Single Test Panels Market by Country, 2022 - 2028, USD Million
• TABLE 147 Europe Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 148 Europe Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 149 Europe Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
• TABLE 150 Europe Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
• TABLE 151 Europe Inflammation Tests Market by Country, 2018 - 2021, USD Million
• TABLE 152 Europe Inflammation Tests Market by Country, 2022 - 2028, USD Million
• TABLE 153 Europe Telomere Tests Market by Country, 2018 - 2021, USD Million
• TABLE 154 Europe Telomere Tests Market by Country, 2022 - 2028, USD Million
• TABLE 155 Europe Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
• TABLE 156 Europe Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
• TABLE 157 Europe Multi-test Panels Market by Country, 2018 - 2021, USD Million
• TABLE 158 Europe Multi-test Panels Market by Country, 2022 - 2028, USD Million
• TABLE 159 Europe Cellular Health Screening Market by Country, 2018 - 2021, USD Million
• TABLE 160 Europe Cellular Health Screening Market by Country, 2022 - 2028, USD Million
• TABLE 161 Germany Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 162 Germany Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 163 Germany Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 164 Germany Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 165 Germany Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 166 Germany Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 167 Germany Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 168 Germany Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 169 Germany Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 170 Germany Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 171 UK Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 172 UK Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 173 UK Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 174 UK Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 175 UK Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 176 UK Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 177 UK Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 178 UK Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 179 UK Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 180 UK Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 181 France Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 182 France Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 183 France Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 184 France Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 185 France Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 186 France Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 187 France Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 188 France Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 189 France Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 190 France Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 191 Russia Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 192 Russia Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 193 Russia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 194 Russia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 195 Russia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 196 Russia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 197 Russia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 198 Russia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 199 Russia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 200 Russia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 201 Spain Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 202 Spain Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 203 Spain Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 204 Spain Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 205 Spain Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 206 Spain Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 207 Spain Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 208 Spain Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 209 Spain Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 210 Spain Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 211 Italy Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 212 Italy Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 213 Italy Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 214 Italy Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 215 Italy Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 216 Italy Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 217 Italy Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 218 Italy Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 219 Italy Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 220 Italy Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 221 Rest of Europe Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 222 Rest of Europe Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 223 Rest of Europe Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 224 Rest of Europe Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 225 Rest of Europe Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 226 Rest of Europe Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 227 Rest of Europe Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 228 Rest of Europe Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 229 Rest of Europe Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 230 Rest of Europe Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 231 Asia Pacific Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 232 Asia Pacific Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 233 Asia Pacific Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 234 Asia Pacific Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 235 Asia Pacific Blood Market by Country, 2018 - 2021, USD Million
• TABLE 236 Asia Pacific Blood Market by Country, 2022 - 2028, USD Million
• TABLE 237 Asia Pacific Saliva Market by Country, 2018 - 2021, USD Million
• TABLE 238 Asia Pacific Saliva Market by Country, 2022 - 2028, USD Million
• TABLE 239 Asia Pacific Serum Market by Country, 2018 - 2021, USD Million
• TABLE 240 Asia Pacific Serum Market by Country, 2022 - 2028, USD Million
• TABLE 241 Asia Pacific Urine Market by Country, 2018 - 2021, USD Million
• TABLE 242 Asia Pacific Urine Market by Country, 2022 - 2028, USD Million
• TABLE 243 Asia Pacific Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 244 Asia Pacific Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 245 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
• TABLE 246 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
• TABLE 247 Asia Pacific Diagnostic Labs Market by Country, 2018 - 2021, USD Million
• TABLE 248 Asia Pacific Diagnostic Labs Market by Country, 2022 - 2028, USD Million
• TABLE 249 Asia Pacific Home Market by Country, 2018 - 2021, USD Million
• TABLE 250 Asia Pacific Home Market by Country, 2022 - 2028, USD Million
• TABLE 251 Asia Pacific Office Market by Country, 2018 - 2021, USD Million
• TABLE 252 Asia Pacific Office Market by Country, 2022 - 2028, USD Million
• TABLE 253 Asia Pacific Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 254 Asia Pacific Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 255 Asia Pacific Single Test Panels Market by Country, 2018 - 2021, USD Million
• TABLE 256 Asia Pacific Single Test Panels Market by Country, 2022 - 2028, USD Million
• TABLE 257 Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 258 Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 259 Asia Pacific Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
• TABLE 260 Asia Pacific Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
• TABLE 261 Asia Pacific Inflammation Tests Market by Country, 2018 - 2021, USD Million
• TABLE 262 Asia Pacific Inflammation Tests Market by Country, 2022 - 2028, USD Million
• TABLE 263 Asia Pacific Telomere Tests Market by Country, 2018 - 2021, USD Million
• TABLE 264 Asia Pacific Telomere Tests Market by Country, 2022 - 2028, USD Million
• TABLE 265 Asia Pacific Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
• TABLE 266 Asia Pacific Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
• TABLE 267 Asia Pacific Multi-test Panels Market by Country, 2018 - 2021, USD Million
• TABLE 268 Asia Pacific Multi-test Panels Market by Country, 2022 - 2028, USD Million
• TABLE 269 Asia Pacific Cellular Health Screening Market by Country, 2018 - 2021, USD Million
• TABLE 270 Asia Pacific Cellular Health Screening Market by Country, 2022 - 2028, USD Million
• TABLE 271 China Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 272 China Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 273 China Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 274 China Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 275 China Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 276 China Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 277 China Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 278 China Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 279 China Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 280 China Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 281 Japan Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 282 Japan Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 283 Japan Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 284 Japan Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 285 Japan Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 286 Japan Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 287 Japan Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 288 Japan Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 289 Japan Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 290 Japan Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 291 India Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 292 India Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 293 India Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 294 India Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 295 India Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 296 India Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 297 India Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 298 India Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 299 India Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 300 India Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 301 Australia Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 302 Australia Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 303 Australia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 304 Australia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 305 Australia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 306 Australia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 307 Australia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 308 Australia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 309 Australia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 310 Australia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 311 South Korea Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 312 South Korea Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 313 South Korea Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 314 South Korea Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 315 South Korea Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 316 South Korea Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 317 South Korea Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 318 South Korea Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 319 South Korea Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 320 South Korea Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 321 Malaysia Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 322 Malaysia Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 323 Malaysia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 324 Malaysia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 325 Malaysia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 326 Malaysia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 327 Malaysia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 328 Malaysia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 329 Malaysia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 330 Malaysia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 331 Rest of Asia Pacific Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 332 Rest of Asia Pacific Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 333 Rest of Asia Pacific Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 334 Rest of Asia Pacific Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 335 Rest of Asia Pacific Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 336 Rest of Asia Pacific Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 337 Rest of Asia Pacific Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 338 Rest of Asia Pacific Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 339 Rest of Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 340 Rest of Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million

• TABLE 341 LAMEA Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 342 LAMEA Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 343 LAMEA Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 344 LAMEA Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 345 LAMEA Blood Market by Country, 2018 - 2021, USD Million
• TABLE 346 LAMEA Blood Market by Country, 2022 - 2028, USD Million
• TABLE 347 LAMEA Saliva Market by Country, 2018 - 2021, USD Million
• TABLE 348 LAMEA Saliva Market by Country, 2022 - 2028, USD Million
• TABLE 349 LAMEA Serum Market by Country, 2018 - 2021, USD Million
• TABLE 350 LAMEA Serum Market by Country, 2022 - 2028, USD Million
• TABLE 351 LAMEA Urine Market by Country, 2018 - 2021, USD Million
• TABLE 352 LAMEA Urine Market by Country, 2022 - 2028, USD Million
• TABLE 353 LAMEA Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 354 LAMEA Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 355 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
• TABLE 356 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
• TABLE 357 LAMEA Diagnostic Labs Market by Country, 2018 - 2021, USD Million
• TABLE 358 LAMEA Diagnostic Labs Market by Country, 2022 - 2028, USD Million
• TABLE 359 LAMEA Home Market by Country, 2018 - 2021, USD Million
• TABLE 360 LAMEA Home Market by Country, 2022 - 2028, USD Million
• TABLE 361 LAMEA Office Market by Country, 2018 - 2021, USD Million
• TABLE 362 LAMEA Office Market by Country, 2022 - 2028, USD Million
• TABLE 363 LAMEA Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 364 LAMEA Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 365 LAMEA Single Test Panels Market by Country, 2018 - 2021, USD Million
• TABLE 366 LAMEA Single Test Panels Market by Country, 2022 - 2028, USD Million
• TABLE 367 LAMEA Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 368 LAMEA Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 369 LAMEA Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
• TABLE 370 LAMEA Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
• TABLE 371 LAMEA Inflammation Tests Market by Country, 2018 - 2021, USD Million
• TABLE 372 LAMEA Inflammation Tests Market by Country, 2022 - 2028, USD Million
• TABLE 373 LAMEA Telomere Tests Market by Country, 2018 - 2021, USD Million
• TABLE 374 LAMEA Telomere Tests Market by Country, 2022 - 2028, USD Million
• TABLE 375 LAMEA Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
• TABLE 376 LAMEA Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
• TABLE 377 LAMEA Multi-test Panels Market by Country, 2018 - 2021, USD Million
• TABLE 378 LAMEA Multi-test Panels Market by Country, 2022 - 2028, USD Million
• TABLE 379 LAMEA Cellular Health Screening Market by Country, 2018 - 2021, USD Million
• TABLE 380 LAMEA Cellular Health Screening Market by Country, 2022 - 2028, USD Million
• TABLE 381 Brazil Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 382 Brazil Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 383 Brazil Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 384 Brazil Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 385 Brazil Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 386 Brazil Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 387 Brazil Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 388 Brazil Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 389 Brazil Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 390 Brazil Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 391 Argentina Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 392 Argentina Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 393 Argentina Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 394 Argentina Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 395 Argentina Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 396 Argentina Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 397 Argentina Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 398 Argentina Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 399 Argentina Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 400 Argentina Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 401 UAE Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 402 UAE Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 403 UAE Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 404 UAE Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 405 UAE Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 406 UAE Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 407 UAE Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 408 UAE Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 409 UAE Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 410 UAE Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 411 Saudi Arabia Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 412 Saudi Arabia Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 413 Saudi Arabia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 414 Saudi Arabia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 415 Saudi Arabia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 416 Saudi Arabia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 417 Saudi Arabia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 418 Saudi Arabia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 419 Saudi Arabia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 420 Saudi Arabia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 421 South Africa Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 422 South Africa Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 423 South Africa Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 424 South Africa Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 425 South Africa Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 426 South Africa Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 427 South Africa Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 428 South Africa Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 429 South Africa Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 430 South Africa Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 431 Nigeria Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 432 Nigeria Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 433 Nigeria Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 434 Nigeria Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 435 Nigeria Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 436 Nigeria Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 437 Nigeria Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 438 Nigeria Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 439 Nigeria Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 440 Nigeria Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 441 Rest of LAMEA Cellular Health Screening Market, 2018 - 2021, USD Million
• TABLE 442 Rest of LAMEA Cellular Health Screening Market, 2022 - 2028, USD Million
• TABLE 443 Rest of LAMEA Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
• TABLE 444 Rest of LAMEA Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
• TABLE 445 Rest of LAMEA Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
• TABLE 446 Rest of LAMEA Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
• TABLE 447 Rest of LAMEA Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
• TABLE 448 Rest of LAMEA Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
• TABLE 449 Rest of LAMEA Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
• TABLE 450 Rest of LAMEA Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
• TABLE 451 Key information - Quest Diagnostics Incorporated
• TABLE 452 Key Information - OPKO Health, Inc.
• TABLE 453 Key Information - Laboratory Corporation of America holdings
• TABLE 454 Key Information - Genova Diagnostics
• TABLE 455 Key Information - Telomere Diagnostics, Inc.
• TABLE 456 Key Information - LIFE LENGTH, S.L.
• TABLE 457 Key Information - Repeat Diagnostics, Inc.
• TABLE 458 Key Information - SpectraCell Laboratories, Inc.
• TABLE 459 Key Information - Cell Science Systems Corp.
• TABLE 460 Key Information - SEGTERRA (INSIDETRACKER)

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Cellular Health Screening Market share by Sample Type, 2021
• FIG 3 Global Cellular Health Screening Market share by Sample Type, 2028
• FIG 4 Global Cellular Health Screening Market by Sample Type, 2018 - 2028, USD Million
• FIG 5 Global Cellular Health Screening Market share by Collection Site, 2021
• FIG 6 Global Cellular Health Screening Market share by Collection Site, 2028
• FIG 7 Global Cellular Health Screening Market by Collection Site, 2018 - 2028, USD Million
• FIG 8 Global Cellular Health Screening Market share by Test Type, 2021
• FIG 9 Global Cellular Health Screening Market share by Test Type, 2028
• FIG 10 Global Cellular Health Screening Market by Test Type, 2018 - 2028, USD Million
• FIG 11 Global Cellular Health Screening Market share by Region, 2021
• FIG 12 Global Cellular Health Screening Market share by Region, 2028
• FIG 13 Global Cellular Health Screening Market by Region, 2018 - 2028, USD Million
• FIG 14 Recent strategies and developments: Quest Diagnostics Incorporated

The Global Cellular Health Screening Market size is expected to reach $4.3 billion by 2028, rising at a market growth of 9.0% CAGR during the forecast period.

Cellular health screening is a cutting-edge innovation used to quickly assess cellular health. The screening illustrates how the cells function in relation to the body. The screening aids in determining conditions such as cellular toxicity, fat mass, cellular capabilities, dynamic tissue mass, and extracellular and intracellular liquid levels. The fundamental components of life are cells, which come together to form organs.

Bio-energy is produced by healthy cells, which eventually results in normal health. Since it can accurately assess a person's level of health and provide details about cellular health and performance, cellular health screening has grown in importance in recent years. This screening method helps doctors and other healthcare professionals better understand how cells in the body behave and function.

A key component of precision medicine is the easy monitoring and control of treatment options made possible by cellular health screening. Additionally, it provides information on cellular activity and muscle mass, which has increased its adoption in routine health examinations.

When a person does not exhibit any symptoms of a condition, a screening test is performed to look for probable health issues or diseases. The objective is early identification, lifestyle modifications, or surveillance to lower the likelihood of disease or to identify it soon enough to receive the best possible care.

Covid-19 Impact Analysis

As a consequence of the COVID-19 pandemic, businesses that provide cellular health screening products and services saw a decline in their revenues and base testing volume. Along with the government directives connected to the pandemic, the supply chain was hampered by transportation constraints and prohibitions on the export and import of commodities and raw materials. Consequently, many companies expanded their product offerings to incorporate COVID-19 antibody and molecular testing in response to the fall in demand brought on by the interruption of the supply chain, which could balance the decrease in a base testing capacity.

Market Growth Factors

Rise in the global geriatric population

Cellular health screening is essential because aging and poor lifestyles are the main sources of dietary imbalances in the human body. Commercially available supplements are available to boost nutritional levels. The fundamental cause of oxidative stress, fatigue, stress, as well as other symptoms is a decline in cell health. However, a lack of necessary nutrients will gradually limit cells' ability to operate normally, which will lead to sickness. The levels of NAD+, an enzyme needed by every cell for optimal operation, decrease by half between the ages of 40 and 60. Additionally, a shorter telomere can result in a number of side effects, including liver illness, lung fibrosis, and bone marrow failure.

Expanded Use of Personalized Medicines

The growth of cellular health screening is attributed to its expanding use in personalized medicine. The International Consortium for Personalized Medicine (ICPerMed) considers that technology innovation, along with the advancement of the biomedical, social, and economic sciences, is what propels PM. Therefore, a significant investment in innovation and research is necessary for its successful execution. Personalized medicine generally consists of two components. A biological, medication or any other form of therapeutic intervention is the first, and a diagnostic test is the second.

Market Restraining Factors

High cost of cellular screening kits and lack of specialized workers

The cost of cellular health screening kits can be high, which sustains their usage by the majority beyond a point. Another aspect that has an impact on the growth of Cellular Health Screening is the fragility of samples and the instability of kits. Both of these reduce the responsiveness of the program and the efficiency of the process. Their high maintenance has made them ineligible to be used in every case, especially in cases where the sample collection is limited. Additionally, the rising sample transportation challenges and unfavorable reimbursement policies decline the preference for cellular health screening kits.

Sample Type Outlook

On the basis of sample type, the cellular health screening market is divided into blood, saliva, serum, and urine. The urine sample segment witnessed a significant revenue share in the cellular health screening market in 2021. Since urine collection does not require technical people and is non-invasive, it is patient-friendly and significantly quicker. Additionally, studies have shown that urine screening may accurately assess oxidative stress. For instance, researchers from Japan demonstrated in a study article that smoking and oxidative stress are linked to the level of pteridine compounds in urine. As a result, the market for urine sample type screening is predicted to rise as a result of the growing screening of oxidative stress in the body.

Collection Site Outlook

Based on collection site, the cellular health screening market is segmented into home, office, hospital, and diagnostic labs. The home segment procured a promising revenue share in the cellular health screening market in 2021. This is explained by rising health consciousness and the widespread use of self-sampling in important marketplaces. Self-sampling has become popular because it is simple to use and doesn't call for specialized equipment or qualified personnel. Additionally, the COVID-19 pandemic resulted in a widespread inclination for home collections because of the restrictions on movement, and this inclination will persist for years to come.

Test Type Outlook

Based on test type, the cellular health screening market is categorized into single test panels and multi-test panels. The single test panels dominated the cellular health screening market with the highest revenue share in 2021. Products for single-panel tests offer affordable, precise, and quick screening for a specific, particular class of disease. Simple single panel tests use a sample to detect biomarkers that could be precursors for the disease. Such diagnostic tests are appropriate for both business and personal use, whether conducted in the workplace or at home. Within minutes, tests produce qualitative data that are visible and easy to comprehend.

Oxidative Stress Tests Outlook

The single test panels segment is further divided into telomere tests, oxidative stress tests, inflammation tests, and heavy metals tests. The oxidative stress tests acquired the largest revenue share in the cellular health screening market in 2021. Cancer, respiratory conditions, diabetes, cardiovascular conditions, and other illnesses are helped by these tests. Oxidative stress is a result of an imbalance between the generation of free radicals (ROS, or reactive oxygen species), and the body's already-existing antioxidant capacity (AC). An enhancement in antioxidant capacity frequently results in a decrease in ROS generation, whilst a rise in the AC may result in a drop in ROS values.

Regional Outlook

On the basis of region, the cellular health screening market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North American region recorded the largest revenue share in the cellular health screening market in 2021. Healthy Life Expectancy (HALE), which measures how long people live in good health, rising healthcare costs, and government support for preventative care are some of the major contributing elements in this area. Additionally, the existence of significant important players, the simplicity with which new technologies are adopted, and the prevalence of chronic and infectious diseases among the populace all contribute to regional growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc.

Cellular Health Screening Market Report Coverage:

Report Attribute Details

Market size value in 2021 USD 2.4 Billion

Market size forecast in 2028 USD 4.3 Billion

Base Year 2021

Historical period 2018 to 2020

Forecast Period 2022 to 2028

Revenue Growth Rate CAGR of 9% from 2022 to 2028

Number of Pages 250

Tables 460

Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling

Segments covered Sample Type, Collection Site, Test Type, Region

Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Australia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria

Growth Drivers * Rise in the global geriatric population

Expanded Use of Personalized Medicines

Restraints * High cost of cellular screening kits and lack of specialized workers

Scope of the Study

Market Segments covered in the Report:

By Sample Type

• Blood
• Saliva
• Serum
• Urine

By Collection Site

• Hospital
• Diagnostic Labs
• Home
• Office

By Test Type

• Single Test Panels
  • Oxidative Stress Tests
  • Inflammation Tests
  • Telomere Tests
  • Heavy Metals Tests
• Multi-test Panels

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Quest Diagnostics Incorporated
• OPKO Health, Inc.
• Laboratory Corporation of America Holdings
• Genova Diagnostics
• Telomere Diagnostics, Inc.
• Life Length, S.L.
• Repeat Diagnostics, Inc.
• SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
• Cell Science Systems Corp.
• Segterra, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Cellular Health Screening Market, by Sample Type
  • 1.4.2 Global Cellular Health Screening Market, by Collection Site
  • 1.4.3 Global Cellular Health Screening Market, by Test Type
  • 1.4.4 Global Cellular Health Screening Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Composition and Scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Global Cellular Health Screening Market by Sample Type

• 3.1 Global Blood Market by Region
• 3.2 Global Saliva Market by Region
• 3.3 Global Serum Market by Region
• 3.4 Global Urine Market by Region

Chapter 4. Global Cellular Health Screening Market by Collection Site

• 4.1 Global Hospital Market by Region
• 4.2 Global Diagnostic Labs Market by Region
• 4.3 Global Home Market by Region
• 4.4 Global Office Market by Region

Chapter 5. Global Cellular Health Screening Market by Test Type

• 5.1 Global Single Test Panels Market by Region
• 5.2 Global Cellular Health Screening Market by Single Test Panels Type
  • 5.2.1 Global Oxidative Stress Tests Market by Region
  • 5.2.2 Global Inflammation Tests Market by Region
  • 5.2.3 Global Telomere Tests Market by Region
  • 5.2.4 Global Heavy Metals Tests Market by Region
• 5.3 Global Multi-test Panels Market by Region

Chapter 6. Global Cellular Health Screening Market by Region

• 6.1 North America Cellular Health Screening Market
  • 6.1.1 North America Cellular Health Screening Market by Sample Type
    • 6.1.1.1 North America Blood Market by Country
    • 6.1.1.2 North America Saliva Market by Country
    • 6.1.1.3 North America Serum Market by Country
    • 6.1.1.4 North America Urine Market by Country
  • 6.1.2 North America Cellular Health Screening Market by Collection Site
    • 6.1.2.1 North America Hospital Market by Country
    • 6.1.2.2 North America Diagnostic Labs Market by Country
    • 6.1.2.3 North America Home Market by Country
    • 6.1.2.4 North America Office Market by Country
  • 6.1.3 North America Cellular Health Screening Market by Test Type
    • 6.1.3.1 North America Single Test Panels Market by Country
    • 6.1.3.2 North America Cellular Health Screening Market by Single Test Panels Type
      • 6.1.3.2.1 North America Oxidative Stress Tests Market by Country
      • 6.1.3.2.2 North America Inflammation Tests Market by Country
      • 6.1.3.2.3 North America Telomere Tests Market by Country
      • 6.1.3.2.4 North America Heavy Metals Tests Market by Country
    • 6.1.3.3 North America Multi-test Panels Market by Country
  • 6.1.4 North America Cellular Health Screening Market by Country
    • 6.1.4.1 US Cellular Health Screening Market
      • 6.1.4.1.1 US Cellular Health Screening Market by Sample Type
      • 6.1.4.1.2 US Cellular Health Screening Market by Collection Site
      • 6.1.4.1.3 US Cellular Health Screening Market by Test Type
    • 6.1.4.2 Canada Cellular Health Screening Market
      • 6.1.4.2.1 Canada Cellular Health Screening Market by Sample Type
      • 6.1.4.2.2 Canada Cellular Health Screening Market by Collection Site
      • 6.1.4.2.3 Canada Cellular Health Screening Market by Test Type
    • 6.1.4.3 Mexico Cellular Health Screening Market
      • 6.1.4.3.1 Mexico Cellular Health Screening Market by Sample Type
      • 6.1.4.3.2 Mexico Cellular Health Screening Market by Collection Site
      • 6.1.4.3.3 Mexico Cellular Health Screening Market by Test Type
    • 6.1.4.4 Rest of North America Cellular Health Screening Market
      • 6.1.4.4.1 Rest of North America Cellular Health Screening Market by Sample Type
      • 6.1.4.4.2 Rest of North America Cellular Health Screening Market by Collection Site
      • 6.1.4.4.3 Rest of North America Cellular Health Screening Market by Test Type
• 6.2 Europe Cellular Health Screening Market
  • 6.2.1 Europe Cellular Health Screening Market by Sample Type
    • 6.2.1.1 Europe Blood Market by Country
    • 6.2.1.2 Europe Saliva Market by Country
    • 6.2.1.3 Europe Serum Market by Country
    • 6.2.1.4 Europe Urine Market by Country
  • 6.2.2 Europe Cellular Health Screening Market by Collection Site
    • 6.2.2.1 Europe Hospital Market by Country
    • 6.2.2.2 Europe Diagnostic Labs Market by Country
    • 6.2.2.3 Europe Home Market by Country
    • 6.2.2.4 Europe Office Market by Country
  • 6.2.3 Europe Cellular Health Screening Market by Test Type
    • 6.2.3.1 Europe Single Test Panels Market by Country
    • 6.2.3.2 Europe Cellular Health Screening Market by Single Test Panels Type
      • 6.2.3.2.1 Europe Oxidative Stress Tests Market by Country
      • 6.2.3.2.2 Europe Inflammation Tests Market by Country
      • 6.2.3.2.3 Europe Telomere Tests Market by Country
      • 6.2.3.2.4 Europe Heavy Metals Tests Market by Country
    • 6.2.3.3 Europe Multi-test Panels Market by Country
  • 6.2.4 Europe Cellular Health Screening Market by Country
    • 6.2.4.1 Germany Cellular Health Screening Market
      • 6.2.4.1.1 Germany Cellular Health Screening Market by Sample Type
      • 6.2.4.1.2 Germany Cellular Health Screening Market by Collection Site
      • 6.2.4.1.3 Germany Cellular Health Screening Market by Test Type
    • 6.2.4.2 UK Cellular Health Screening Market
      • 6.2.4.2.1 UK Cellular Health Screening Market by Sample Type
      • 6.2.4.2.2 UK Cellular Health Screening Market by Collection Site
      • 6.2.4.2.3 UK Cellular Health Screening Market by Test Type
    • 6.2.4.3 France Cellular Health Screening Market
      • 6.2.4.3.1 France Cellular Health Screening Market by Sample Type
      • 6.2.4.3.2 France Cellular Health Screening Market by Collection Site
      • 6.2.4.3.3 France Cellular Health Screening Market by Test Type
    • 6.2.4.4 Russia Cellular Health Screening Market
      • 6.2.4.4.1 Russia Cellular Health Screening Market by Sample Type
      • 6.2.4.4.2 Russia Cellular Health Screening Market by Collection Site
      • 6.2.4.4.3 Russia Cellular Health Screening Market by Test Type
    • 6.2.4.5 Spain Cellular Health Screening Market
      • 6.2.4.5.1 Spain Cellular Health Screening Market by Sample Type
      • 6.2.4.5.2 Spain Cellular Health Screening Market by Collection Site
      • 6.2.4.5.3 Spain Cellular Health Screening Market by Test Type
    • 6.2.4.6 Italy Cellular Health Screening Market
      • 6.2.4.6.1 Italy Cellular Health Screening Market by Sample Type
      • 6.2.4.6.2 Italy Cellular Health Screening Market by Collection Site
      • 6.2.4.6.3 Italy Cellular Health Screening Market by Test Type
    • 6.2.4.7 Rest of Europe Cellular Health Screening Market
      • 6.2.4.7.1 Rest of Europe Cellular Health Screening Market by Sample Type
      • 6.2.4.7.2 Rest of Europe Cellular Health Screening Market by Collection Site
      • 6.2.4.7.3 Rest of Europe Cellular Health Screening Market by Test Type
• 6.3 Asia Pacific Cellular Health Screening Market
  • 6.3.1 Asia Pacific Cellular Health Screening Market by Sample Type
    • 6.3.1.1 Asia Pacific Blood Market by Country
    • 6.3.1.2 Asia Pacific Saliva Market by Country
    • 6.3.1.3 Asia Pacific Serum Market by Country
    • 6.3.1.4 Asia Pacific Urine Market by Country
  • 6.3.2 Asia Pacific Cellular Health Screening Market by Collection Site
    • 6.3.2.1 Asia Pacific Hospital Market by Country
    • 6.3.2.2 Asia Pacific Diagnostic Labs Market by Country
    • 6.3.2.3 Asia Pacific Home Market by Country
    • 6.3.2.4 Asia Pacific Office Market by Country
  • 6.3.3 Asia Pacific Cellular Health Screening Market by Test Type
    • 6.3.3.1 Asia Pacific Single Test Panels Market by Country
    • 6.3.3.2 Asia Pacific Cellular Health Screening Market by Single Test Panels Type
      • 6.3.3.2.1 Asia Pacific Oxidative Stress Tests Market by Country
      • 6.3.3.2.2 Asia Pacific Inflammation Tests Market by Country
      • 6.3.3.2.3 Asia Pacific Telomere Tests Market by Country
      • 6.3.3.2.4 Asia Pacific Heavy Metals Tests Market by Country
    • 6.3.3.3 Asia Pacific Multi-test Panels Market by Country
  • 6.3.4 Asia Pacific Cellular Health Screening Market by Country
    • 6.3.4.1 China Cellular Health Screening Market
      • 6.3.4.1.1 China Cellular Health Screening Market by Sample Type
      • 6.3.4.1.2 China Cellular Health Screening Market by Collection Site
      • 6.3.4.1.3 China Cellular Health Screening Market by Test Type
    • 6.3.4.2 Japan Cellular Health Screening Market
      • 6.3.4.2.1 Japan Cellular Health Screening Market by Sample Type
      • 6.3.4.2.2 Japan Cellular Health Screening Market by Collection Site
      • 6.3.4.2.3 Japan Cellular Health Screening Market by Test Type
    • 6.3.4.3 India Cellular Health Screening Market
      • 6.3.4.3.1 India Cellular Health Screening Market by Sample Type
      • 6.3.4.3.2 India Cellular Health Screening Market by Collection Site
      • 6.3.4.3.3 India Cellular Health Screening Market by Test Type
    • 6.3.4.4 Australia Cellular Health Screening Market
      • 6.3.4.4.1 Australia Cellular Health Screening Market by Sample Type
      • 6.3.4.4.2 Australia Cellular Health Screening Market by Collection Site
      • 6.3.4.4.3 Australia Cellular Health Screening Market by Test Type
    • 6.3.4.5 South Korea Cellular Health Screening Market
      • 6.3.4.5.1 South Korea Cellular Health Screening Market by Sample Type
      • 6.3.4.5.2 South Korea Cellular Health Screening Market by Collection Site
      • 6.3.4.5.3 South Korea Cellular Health Screening Market by Test Type
    • 6.3.4.6 Malaysia Cellular Health Screening Market
      • 6.3.4.6.1 Malaysia Cellular Health Screening Market by Sample Type
      • 6.3.4.6.2 Malaysia Cellular Health Screening Market by Collection Site
      • 6.3.4.6.3 Malaysia Cellular Health Screening Market by Test Type
    • 6.3.4.7 Rest of Asia Pacific Cellular Health Screening Market
      • 6.3.4.7.1 Rest of Asia Pacific Cellular Health Screening Market by Sample Type
      • 6.3.4.7.2 Rest of Asia Pacific Cellular Health Screening Market by Collection Site
      • 6.3.4.7.3 Rest of Asia Pacific Cellular Health Screening Market by Test Type
• 6.4 LAMEA Cellular Health Screening Market
  • 6.4.1 LAMEA Cellular Health Screening Market by Sample Type
    • 6.4.1.1 LAMEA Blood Market by Country
    • 6.4.1.2 LAMEA Saliva Market by Country
    • 6.4.1.3 LAMEA Serum Market by Country
    • 6.4.1.4 LAMEA Urine Market by Country
  • 6.4.2 LAMEA Cellular Health Screening Market by Collection Site
    • 6.4.2.1 LAMEA Hospital Market by Country
    • 6.4.2.2 LAMEA Diagnostic Labs Market by Country
    • 6.4.2.3 LAMEA Home Market by Country
    • 6.4.2.4 LAMEA Office Market by Country
  • 6.4.3 LAMEA Cellular Health Screening Market by Test Type
    • 6.4.3.1 LAMEA Single Test Panels Market by Country
    • 6.4.3.2 LAMEA Cellular Health Screening Market by Single Test Panels Type
      • 6.4.3.2.1 LAMEA Oxidative Stress Tests Market by Country
      • 6.4.3.2.2 LAMEA Inflammation Tests Market by Country
      • 6.4.3.2.3 LAMEA Telomere Tests Market by Country
      • 6.4.3.2.4 LAMEA Heavy Metals Tests Market by Country
    • 6.4.3.3 LAMEA Multi-test Panels Market by Country
  • 6.4.4 LAMEA Cellular Health Screening Market by Country
    • 6.4.4.1 Brazil Cellular Health Screening Market
      • 6.4.4.1.1 Brazil Cellular Health Screening Market by Sample Type
      • 6.4.4.1.2 Brazil Cellular Health Screening Market by Collection Site
      • 6.4.4.1.3 Brazil Cellular Health Screening Market by Test Type
    • 6.4.4.2 Argentina Cellular Health Screening Market
      • 6.4.4.2.1 Argentina Cellular Health Screening Market by Sample Type
      • 6.4.4.2.2 Argentina Cellular Health Screening Market by Collection Site
      • 6.4.4.2.3 Argentina Cellular Health Screening Market by Test Type
    • 6.4.4.3 UAE Cellular Health Screening Market
      • 6.4.4.3.1 UAE Cellular Health Screening Market by Sample Type
      • 6.4.4.3.2 UAE Cellular Health Screening Market by Collection Site
      • 6.4.4.3.3 UAE Cellular Health Screening Market by Test Type
    • 6.4.4.4 Saudi Arabia Cellular Health Screening Market
      • 6.4.4.4.1 Saudi Arabia Cellular Health Screening Market by Sample Type
      • 6.4.4.4.2 Saudi Arabia Cellular Health Screening Market by Collection Site
      • 6.4.4.4.3 Saudi Arabia Cellular Health Screening Market by Test Type
    • 6.4.4.5 South Africa Cellular Health Screening Market
      • 6.4.4.5.1 South Africa Cellular Health Screening Market by Sample Type
      • 6.4.4.5.2 South Africa Cellular Health Screening Market by Collection Site
      • 6.4.4.5.3 South Africa Cellular Health Screening Market by Test Type
    • 6.4.4.6 Nigeria Cellular Health Screening Market
      • 6.4.4.6.1 Nigeria Cellular Health Screening Market by Sample Type
      • 6.4.4.6.2 Nigeria Cellular Health Screening Market by Collection Site
      • 6.4.4.6.3 Nigeria Cellular Health Screening Market by Test Type
    • 6.4.4.7 Rest of LAMEA Cellular Health Screening Market
      • 6.4.4.7.1 Rest of LAMEA Cellular Health Screening Market by Sample Type
      • 6.4.4.7.2 Rest of LAMEA Cellular Health Screening Market by Collection Site
      • 6.4.4.7.3 Rest of LAMEA Cellular Health Screening Market by Test Type

Chapter 7. Company Profiles

• 7.1 Quest Diagnostics Incorporated
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental Analysis
  • 7.1.4 Recent strategies and developments:
    • 7.1.4.1 Partnerships, Collaborations, and Agreements:
    • 7.1.4.2 Product Launches and Product Expansions:
• 7.2 OPKO Health, Inc.
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental and Regional Analysis
  • 7.2.4 Research & Development Expenses
• 7.3 Laboratory Corporation of America Holdings
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Segmental Analysis
• 7.4 Genova Diagnostics
  • 7.4.1 Company Overview
  • 7.4.2 Recent strategies and developments:
    • 7.4.2.1 Partnerships, Collaborations, and Agreements:
• 7.5 Telomere Diagnostics, Inc.
  • 7.5.1 Company Overview
• 7.6 Life Length, S.L.
  • 7.6.1 Company Overview
• 7.7 Repeat Diagnostics, Inc.
  • 7.7.1 Company Overview
• 7.8 SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
  • 7.8.1 Company Overview
• 7.9 Cell Science Systems Corp.
  • 7.9.1 Company Overview
• 7.10. Segterra, Inc. (INSIDETRACKER)
  • 7.10.1 Company Overview